Skip to content

Adolescent Projections During Transition in Prader-Willi Syndrome

What Projections Towards the Future During a Period of Transition? A Qualitative Study of Adolescents With Prader-Willi Syndrome

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06279052
Acronym
APT-WILL
Enrollment
20
Registered
2024-02-26
Start date
2024-03-01
Completion date
2024-12-01
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prader-Willi Syndrome

Brief summary

Single-center, cross-sectional qualitative study seeking to collect the experience of adolescence and the transition to adulthood of people affected by Prader-Willi syndrome in a population. To do this, the present will carry out a qualitative study with a reflexive thematic analysis of the data collected through semi-structured interviews using an interview guide.

Interventions

BEHAVIORALPhone interview

Phone interview during which the experience of the transition to adulthood among adolescents and young adults with Prader Willi Syndrome will be retrieved

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

* Patients with genetically confirmed Prader-Willi syndrome * Patients affiliated or beneficiaries of a social security system * Patients known and followed by the reference center, presenting sufficient intellectual skills to answer the interview questions

Exclusion criteria

* Refusal of family participation (if minor) * Refusal of participation by the patient or his guardian (if of legal age)

Design outcomes

Primary

MeasureTime frameDescription
Experience of the disease and aspirations regarding the future1 hourThe main objective of this study is to explore their experience of the disease and their aspirations regarding their future in a population of older adolescents and young adults with Prader-Willi syndrome. A questionnaire created by the clinical investigator containing personal questions will be applied to all patients. There is no scale.

Countries

France

Contacts

Primary ContactGrégoire BENVEGNU
benvegnu.g@chu-toulouse.fr05 34 55 86 78

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026